A new report in the New England Journal of Medicine by researchers at Baylor College of Medicine, Texas Children’s Hospital and Seattle Children’s describes a complete regression of hepatoblastoma, the most common pediatric liver cancer, in a 3-year-old treated with a novel immunotherapy.
This registration marks the Company’s second product authorized in Europe and its first expansion beyond prenatal care into the broader women’s health market
Researchers at the University of Helsinki and HUS Helsinki University Hospital have built normative growth charts for infants’ gross motor development using measurements made in the children’s own homes. In the study, 92 typically developing infants ages 4–19 months wore the MAIJU smart jumpsuit during free play, producing 580 measurements and 1,227 hours of data covering activities from lying on the floor to walking fluently.
YORK, Pa., Sept. 3, 2026 /PRNewswire/ — HR HealthCare today announced the introduction of the Liv™ Pre-lubricated Intermittent Catheter, developed to support women’s bladder management needs. For many women, intermittent self-catheterization is part of daily life alongside work, family, travel, and social commitments. Liv combines protective features with a modern profile and packaging designed to fit into busy lives.
The autonomous triage system’s European market authorisation comes as AI becomes increasingly embedded into the cancer screening paradigm.
Irish medtech company reaches major regulatory milestone for AI-powered technology providing rapid, objective insights into newborn brain activity
Triple-negative breast cancer (TNBC) has a frustrating ability to adapt. Although this aggressive form of breast cancer can initially respond well to chemotherapy, cancer cells often find ways to survive, allowing the disease to return and become resistant to treatment.
Australian researchers have uncovered a promising new way to tackle one of the most aggressive forms of breast cancer, raising hopes for more effective treatments to stop the disease from spreading.
Melbourne researchers have made a gene therapy breakthrough that could restore heart function in children with genetic heart disease, sparing them the need for transplants.
Cancer spreading beyond the primary tumor—a process known as metastasis—is responsible for at least two-thirds of cancer deaths. Drugs targeting metastatic progression have largely failed, in part because of the lack of predictive models that would help identify the underlying mechanisms of metastasis.